Email this article to a friend
Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma
-
* Corresponding author: Florian Eckel Florian.Eckel@lrz.tu-muenchen.de
BMC Cancer 2005, 5:61 doi:10.1186/1471-2407-5-61